NOVONIX Moves to Regain Nasdaq Compliance with 1-for-10 ADS Reverse Split
NVX sits 20% above its 52-week low of $0.369.
Summary
On August 27, 2026, NOVONIX will execute a 1-for-10 reverse split of its American Depositary Shares to push the ADS price above $1.00 and regain Nasdaq listing compliance following a deficiency notice received in March 2026.
Key Events · Corporate Governance and Compliance · NVX
-
ADS Ratio Change Announced
Effective August 27, 2026, the ADS ratio shifts from 1 ADS representing 4 ordinary shares to 1 ADS representing 40 ordinary shares, which equates to a 1-for-10 reverse split of existing ADSs.
-
Nasdaq Minimum Bid Price Deficiency
A Nasdaq non-compliance notice was issued on March 18, 2026, after the ADS closing bid price remained below $1.00 for 30 consecutive business days. The company has 180 days—until mid-September 2026—to regain compliance.
-
Purpose of Ratio Change
The ratio change aims to increase the per-ADS trading price, helping the company meet the $1.00 minimum bid price requirement for at least 10 consecutive business days.
-
No Impact on Ordinary Shares
The adjustment does not alter the number of NOVONIX ordinary shares outstanding or affect its ASX-listed shares; only the ADS representation is modified.
Analysis · NVX · Manufacturing
To address a Nasdaq delisting warning triggered in March 2026 when its ADS price fell below $1.00, NOVONIX is adjusting its ADS ratio from 1:4 to 1:40—effectively a 1-for-10 reverse split of its Nasdaq-listed ADSs. While the underlying ordinary shares and the company's fundamentals remain unchanged, this step is critical for preserving its U.S. listing. A failure to regain compliance would force a move to over-the-counter markets, severely limiting liquidity and institutional access. The company has until September 2026 to achieve 10 consecutive days above $1.00, and this split is designed to mechanically lift the ADS price above that threshold.
At the time of this filing, NVX was trading at $0.44 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $109.1M. The 52-week trading range was $0.37 to $3.86. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.